The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Selective Angiotensin II Receptor Antagonism Reduces Insulin Resistance in Obese Zucker Rats
Open accessAbstract
Effects of oral administration of the angiotensin II receptor antagonist (selective AT 1-subtype) irbesartan on glucose tolerance and insulin action on skeletal-muscle glucose transport were assessed in the insulin-resistant obese Zucker rat. In the acute study, obese rats received either vehicle (water) or irbesartan 1 hour before the experiment. Although irbesartan had no effect on glucose transport (2-deoxyglucose uptake) in the epitrochlearis muscle, which consists mainly of type IIb fibers, acute angiotensin II receptor antagonism led to a dose-dependent increase in insulin action in the predominantly type I soleus muscle. Irbesartan at 25 and 50 mg/kg induced significant increases (41% and 50%, respectively;P<0.05) in insulin-mediated glucose transport. Moreover, these acute irbesartan-induced improvements in soleus-muscle glucose transport were associated with enhancements in whole-body insulin sensitivity (r=−0.732;P<0.05), as assessed during an oral glucose tolerance test. After chronic administration of irbesartan (21 days at 50 mg · kg−1· d−1), glucose tolerance was enhanced further, and insulin-mediated glucose transport was significantly elevated in both epitrochlearis (32%) and soleus (73%) muscle. Chronic angiotensin II receptor antagonism was associated with significant increases in glucose transporter-4 (GLUT-4) protein expression in soleus (22%) and plantaris (20%) muscle and myocardium (15%). Chronic irbesartan-induced increases in whole-body insulin sensitivity were associated with increased insulin-mediated glucose transport in both epitrochlearis (r=−0.677;P<0.05) and soleus (r=−0.892;P<0.05) muscle. In summary, angiotensin II receptor (AT 1-subtype) antagonism, either acutely or chronically, improves glucose tolerance, at least in part because of an enhancement in skeletal-muscle glucose transport, and the effect of chronic angiotensin II receptor antagonism on type I skeletal-muscle glucose uptake is associated with an increase in GLUT-4 protein expression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
DeFronzo, R. A., & Ferrannini, E. (1991) · Diabetes Care · doi:10.2337/diacare.14.3.173 · Cited by 4,535
Role of Fatty Acids in the Pathogenesis of Insulin Resistance and NIDDM
Boden, G. (1997) · Diabetes · doi:10.2337/diab.46.1.3 · Cited by 1,728
HINDLIMB MUSCLE FIBER POPULATIONS OF FIVE MAMMALS
ARIANO, M. A., EDGERTON, V. R., & ARMSTRONG, R. B. (1973) · Journal of Histochemistry & Cytochemistry · doi:10.1177/21.1.51 · Cited by 1,129
Molecular and Cellular Mechanisms of Angiotensin II-Mediated Cardiovascular and Renal Diseases
Kim, S., & Iwao, H. (2000) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01434-0 · Cited by 983
Angiotensin II receptor antagonists
Burnier, M., & Brunner, H. (2000) · The Lancet · doi:10.1016/s0140-6736(99)10365-9 · Cited by 707
Glucose transporter protein content and glucose transport capacity in rat skeletal muscles
Henriksen, E. J., Bourey, R. E., Rodnick, K. J., Koranyi, L., Permutt, M. A., & Holloszy, J. O. (1990) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1990.259.4.e593 · Cited by 434
Self-citationClinical pharmacokinetics of angiotensin II (AT1) receptor blockers in hypertension
Israili, Z. (2000) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1000991 · Cited by 318
Insulin responsiveness in skeletal muscle is determined by glucose transporter (Glut4) protein level
Kern, M., Wells, J. A., Stephens, J. M., Elton, C. W., Friedman, J. E., Tapscott, E. B., Pekala, P. H., & Dohm, G. L. (1990) · Biochemical Journal · doi:10.1042/bj2700397 · Cited by 267
Exercise training, glucose transporters, and glucose transport in rat skeletal muscles
Rodnick, K. J., Henriksen, E. J., James, D. E., & Holloszy, J. O. (1992) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1992.262.1.c9 · Cited by 185
Self-citationUehara, M., Kishikawa, H., Isami, S., Kisanuki, K., Ohkubo, Y., Miyamura, N., Miyata, T., Yano, T., & Shichiri, M. (1994) · Diabetologia · doi:10.1007/bf00398058 · Cited by 141
Jauch, K. ‐., Hartl, W. H., Guenther, B., WICKLMAYR, M., Kristian, R. E. T. T., & Dietze, G. (1987) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1987.tb01141.x · Cited by 140
Crosstalk between insulin and angiotensin II signalling systems
Folli, F. B., Saad, M. J. A., Velloso, L. A., Hansen, H. F., Carandente, O., Feener, E. P., & Kahn, C. R. (2009) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0029-1212088 · Cited by 139
Effects of captopril on glucose transport activity in skeletal muscle of obese Zucker rats
Henriksen, E. J., & Jacob, S. (1995) · Metabolism · doi:10.1016/0026-0495(95)90276-7 · Cited by 137
Self-citationHenriksen, E. J., Jacob, S., Kinnick, T. R., Youngblood, E. B., Schmit, M. B., & Dietze, G. J. (1999) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1999.277.1.r332 · Cited by 137
Self-citationACE inhibition improves insulin-sensitivity in aged insulin-resistant hypertensive patients.
Paolisso, G., Gambardella, A., Verza, M., D’Amore, A., Sgambato, S., & Varricchio, M. T. (1992) · PubMed · Cited by 125
Torlone, E., Rambotti, A. M., Perriello, G., Botta, G., Santeusanio, F., Brunetti, P., & Bolli, G. B. (1991) · Diabetologia · doi:10.1007/bf00500383 · Cited by 114
Angiotensin II induces insulin resistance independent of changes in interstitial insulin
Richey, J. M., Ader, M., Moore, D., & Bergman, R. N. (1999) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1999.277.5.e920 · Cited by 103
Higashiura, K., Ura, N., Takada, T., Li, Y., Torii, T., Togashi, N., Takada, M., Takizawa, H., & Shimamoto, K. (2000) · American Journal of Hypertension · doi:10.1016/s0895-7061(99)00174-0 · Cited by 95
Vuorinen-Markkola, H., & Yki‐Järvinen, H. (1995) · Metabolism · doi:10.1016/0026-0495(95)90293-7 · Cited by 91
Weber, M. (1999) · American Journal of Hypertension · doi:10.1016/s0895-7061(99)00105-3 · Cited by 82
Effects of trandolapril and verapamil on glucose transport in insulin-resistant rat skeletal muscle
Jacob, S., Henriksen, E. J., Fogt, D. L., & Dietze, G. (1996) · Metabolism · doi:10.1016/s0026-0495(96)90021-9 · Cited by 69
Self-citationFogari, R., Zoppi, A., Corradi, L., Lazzari, P., Mugellini, A., & Lusardi, P. (1998) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1998.00811.x · Cited by 68
Henriksen, E. J., Jacob, S., Fogt, D. L., & Dietze, G. J. (1998) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1998.275.1.r40 · Cited by 65
Self-citationEffects of Losartan on Insulin Sensitivity in Hypertensive Subjects
Laakso, M., Karjalainen, L., & Lempiäinen-Kuosa, P. (1996) · Hypertension · doi:10.1161/01.hyp.28.3.392 · Cited by 60
Interactions of exercise training and ACE inhibition on insulin action in obese Zucker rats
Steen, M. S., Foianini, K. R., Youngblood, E. B., Kinnick, T. R., Jacob, S., & Henriksen, E. J. (1999) · Journal of Applied Physiology · doi:10.1152/jappl.1999.86.6.2044 · Cited by 55
Self-citationPonte, D. B. D., Fogt, D. L., Jacob, S., & Henriksen, E. J. (1998) · Metabolism · doi:10.1016/s0026-0495(98)90355-9 · Cited by 52
Self-citationHigashiura, K., Ura, N., Miyazaki, Y., & Shimamoto, K. (1999) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1000748 · Cited by 50
Frossard, M., Joukhadar, C., Steffen, G., Schmid, R., Eichler, H. G., & Müller, M. (2000) · Life Sciences · doi:10.1016/s0024-3205(99)00679-7 · Cited by 44
Pollare, T. (1990) · Journal of Diabetes and its Complications · doi:10.1016/0891-6632(90)90039-8 · Cited by 24
Nakagawa, H., Daihara, M., Tamakawa, H., Nozue, T., & Kawahara, K. (1999) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199907000-00005 · Cited by 24
Harada, N., Onaka, M., Sakamoto, S., Niwa, Y., & Nakaya, Y. (1999) · Cardiovascular Drugs and Therapy · doi:10.1023/a:1007827720807 · Cited by 20
Sasaki, K., Kushiro, T., Nakagawa, S., & Kanmatsuse, K. (1999) · PubMed · Cited by 14
Cited by
Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system
Mehta, P. K., & Griendling, K. K. (2007) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00287.2006 · Cited by 1,924
Benson, S. C., Pershadsingh, H. A., Ho, C. I., Chittiboyina, A., Desai, P., Pravenec, M., Qi, N., Wang, J., Avery, M. A., & Kurtz, T. W. (2004) · Hypertension · doi:10.1161/01.hyp.0000123072.34629.57 · Cited by 1,073
Angiotensin Type 1 Receptor Blockers Induce Peroxisome Proliferator–Activated Receptor-γ Activity
Schupp, M., Janke, J., Clasen, R., Unger, T., & Kintscher, U. (2004) · Circulation · doi:10.1161/01.cir.0000127955.36250.65 · Cited by 705
Oxidative stress and the etiology of insulin resistance and type 2 diabetes
Henriksen, E. J., Diamond-Stanic, M. K., & Marchionne, E. M. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.12.005 · Cited by 600
Self-citationEmerging role of adipose tissue hypoxia in obesity and insulin resistance
Ye, J. (2009) · International Journal of Obesity · doi:10.1038/ijo.2008.229 · Cited by 543
Metadata
- Authors
- Henriksen, E. J., Jacob, S., Kinnick, T. R., Teachey, M. K., & Krekler, M.
- Venue
- Hypertension
- Published
- 2001-10
- Volume
- 38
- Issue
- 4
- Pages
- 884-890
- ISSN
- 0194-911X (ISSN-L)
- 1524-4563
- OpenAlex
- W2156783035
- Cited by
- 293
- References
- 32
- FWCI
- 8.62
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.